EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

Jia-Yi Deng, Qing Gou, Lingling Yang, Zhi-Hong Chen, Ming-Yi Yang, Xiao-Rong Yang, Hong-Hong Yan, Xue-Wu Wei, Jia-Qi Liu, Jian Su, Wen-Zhao Zhong, Chong-Rui Xu iD und 2 weitere

Journal for ImmunoTherapy of Cancer · 2023-07 · 11 (7) · e007218

DOI: 10.1136/jitc-2023-007218 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 18.07.2023. Verfasst von Jia-Yi Deng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzh…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, High-level Hospital Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The liver is a frequent site of metastases and liver metastases (LM) correlate with diminished immunotherapy efficacy in non-small cell lung cancer (NSCLC). This study aimed to analyze whether tumor response to immunotherapy differs between pulmonary lesions (PL) and LM in NSCLC and to explore potential mechanisms through multiomics analysis.

Methods

This observational longitudinal clinical cohort study included patients with NSCLC with LM receiving immunotherapy was conducted to evaluate organ-specific tumor response of PL and LM. We collected paired PL and LM tumor samples to analyze the organ-specific difference using whole-exome sequencing, RNA sequencing, and multiplex immunohistochemistry.

Results

A total of 52 patients with NSCLC with LM were enrolled to evaluate the organ-specific response of immunotherapy. The objective response rate (21.1% vs 32.7%) and disease control rate of LM were lower than that of PL (67.3% vs 86.5%). One-third of patients showed mixed response, among whom 88.2% (15/17) presented with LM increasing, but PL decreasing, while the others had the opposite pattern (p=0.002). In another independent cohort, 27 pairs of matched PL and LM tumor samples from the same individuals, including six simultaneously collected pairs, were included in the translational part. Genomic landscapes profiling revealed similar somatic mutations, tumor mutational burden, and neoantigen number between PL and LM. Bulk-RNA sequencing showed immune activation-related genes including CD8A , LCK , and ICOS were downregulated in LM. The antigen processing and presentation, natural killer (NK) cell-mediated cytotoxicity and T-cell receptor signaling pathway were enriched in PL compared with LM. Multiplex immunohistochemistry detected significantly lower fractions of CD8 + cells (p=0.036) and CD56 dim+ cells (p=0.016) in LM compared with PL. Single-cell RNA sequencing also characterized lower effector CD8 + T cells activation and NK cells cytotoxicity in LM.

Conclusions

Compared with PL, LM presents an inferior organ-specific tumor response to immunotherapy. PL and LM showed limited heterogeneity in the genomic landscape, while the LM tumor microenvironment displayed lower levels of immune activation and infiltration than PL, which might contribute to developing precise immunotherapy strategies for patients with NSCLC with LM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsLiver NeoplasmsHumansCD8-Positive T-LymphocytesCohort StudiesImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

ImmunotherapyLiver NeoplasmsLung NeoplasmsNon-Small Cell Lung CancerTumor Microenvironment

Autor:innen und Institutionen

  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • School of Medicine, South China University of Technology, Guangzhou, China.
  • Department of Interventional Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Geneseeq Research Institute, Nanjing Geneseeq Technology Inc, Nanjing, China.
  • Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China gzzhouqing@126.com.

ORCID-Profile: Chong-Rui Xu, Yi-Long Wu, Qing Zhou

Förderung

  • National Natural Science Foundation of China
  • High-level Hospital Construction Project

Zitieren

APA

Deng, J. Y., Gou, Q., Yang, L., Chen, Z. H., Yang, M. Y., Yang, X. R., Yan, H. H., Wei, X. W., Liu, J. Q., Su, J., Zhong, W. Z., Xu, C. R., Wu, Y. L., & Zhou, Q. (2023). Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer, 11(7), e007218. https://doi.org/10.1136/jitc-2023-007218

Vancouver

Deng JY, Gou Q, Yang L, Chen ZH, Yang MY, Yang XR, et al. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 2023;11(7):e007218. doi:10.1136/jitc-2023-007218

BibTeX
@article{Deng2023,
  author = {Deng, Jia-Yi and Gou, Qing and Yang, Lingling and Chen, Zhi-Hong and Yang, Ming-Yi and Yang, Xiao-Rong and Yan, Hong-Hong and Wei, Xue-Wu and Liu, Jia-Qi and Su, Jian and Zhong, Wen-Zhao and Xu, Chong-Rui and Wu, Yi-Long and Zhou, Qing},
  title = {Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  volume = {11},
  number = {7},
  pages = {e007218},
  doi = {10.1136/jitc-2023-007218}
}
Kostenlos starten →